We investigated the efficacy of ultrasonography-guided breast-conserving surgery in 335 women with palpable breast cancer. We found that ultrasonography-guided breast-conserving surgery is superior to palpation-guided excision in predicting the closest margins, obtaining clear surgical margins, and reducing re-operations. Introduction: The aim of this study was to determine the efficacy of ultrasonography (US)eguided excision of palpable breast cancer and to compare it with the standard palpation-guided breast-conserving surgery (BCS). Methods: For this purpose, 335 women with palpable breast cancer who underwent BCS were retrospectively studied. The positive surgical margins and re-excision rates were investigated. Results: Of the total cohort, 137 patients were treated with palpation-guided BCS and 198 underwent US-guided tumor excision. The tumor and patient characteristics were similar in both groups. Patient age, postmenopausal status, tumor size, histological grade, intraductal tumor component, lobular histology, and palpation-guided tumor excision were associated with increased risk of positive margins. The shave margins were re-excised at the time of original operation more often by palpation-guided localization (28.5%) than by the US-guided procedure (11.1%) (P < .0001). A surgeon was able to correctly identify the "problematic" margin in 81.1% of cases via intraoperative US and in only 17.9% via palpation (P < .0001). The re-excision rate during a second operation was significantly reduced by US-guided tumorectomy (P ¼ .004). Of 198 patients in the US-guided group, 23 (11.6%) underwent a second operation, as did 33 of 137 patients in the palpation group (24.1%). The sensitivity and specificity of US-guided excisions were 52.7% and 97.5%, respectively, whereas the sensitivity and the specificity of palpation-guided tumor excisions were 15.5% and 65.9%, respectively. Conclusion: US-guided BCS is superior to palpation-guided excision in predicting the closest margins, obtaining clear surgical margins, and reducing re-operations.
Introduction
During the past 2 decades, breast-conserving surgery (BCS) followed by adjuvant radiation has become the standard treatment for early breast cancer 1 and is as effective and safe as mastectomy.
1,2
The incidence of inadequate (positive or close) resection margins has been reported to range between 5% and 60%. [3] [4] [5] [6] [7] [8] [9] [10] Although the influence of surgical-margin status on local recurrence is well documented, the impact of positive surgical margins on overall survival (OS) remains a major issue for future debate. 11 In this regard, to reduce the incidence of ipsilateral recurrent disease and to obtain clear pathological margins, the patients undergo re-excision. Various localization methods have been used to obtain adequate surgical margins: palpation-guided, wire-guided, and radio-guided excision. 4, 9, 10, [12] [13] [14] [15] Ultrasonography (US) has been successfully used for imaging-guided breast biopsy and diagnostic procedures. 16, 17 However, intraoperative US was first used for BCS in the late 1980s as an alternative method for detecting nonpalpable breast tumors. 18 Several groups have since tested the feasibility and security of the method for the localization of nonpalpable breast cancers and compared it with the standard radio-guided and wireguided localization techniques. 12, [19] [20] [21] [22] [23] [24] [25] These studies demonstrated the superiority of US-guided localization with regard to obtaining clear surgical margins. Furthermore, intraoperative US could facilitate wire-guided lumpectomy, leading to lower rates of positive margins (26) . Less is known about the use of intraoperative US for BCS of palpable breast cancer. Most series included only a small number of patients, and the benefits of US-guided BCS thus remain controversial. 12, [19] [20] [21] [22] [23] [24] [25] Our goal was to compare the rates of positive resection margins and re-excisions between standard palpation-guided tumor excision and US-guided surgery in a large cohort of breast cancer patients.
Patients and Methods

Patients
The records of patients with breast cancer that was diagnosed in our institution between 2000 and 2011 were retrospectively reviewed. All consecutive patients who underwent preoperative coreneedle biopsy followed by palpation-guided or US-guided BCS were included in the review. Preoperative mammography and sonography were performed. The appearance of specific tumor-associated characteristics on mammography (eg, calcifications, spiculations) was taken into account by the surgeon during the tumorectomy.
The exclusion criteria were the presence of multifocal or multicenter tumors, a history of inflammatory disease, the use of wire-guided or radio-guided preoperative tumor localization, mastectomy, a history of neoadjuvant therapy, previous surgical treatment, previous radiotherapy, and incomplete surgical or pathologic reports.
During the evaluated period, 351 patients fulfilled the study conditions. US-guided BCS had been undertaken in 209 patients between 2006 and 2011. We excluded 11 of these patients from the study, and thus 198 patients were eligible for analysis. The remaining 142 patients had been treated with standard palpationguided BCS in the period between 2000 and 2008. We excluded 5 of these patients, and 137 were thus eligible for analysis. All 16 excluded patients were left out of the study because they had been treated by both palpation-and US-guided tumor localization. Intraoperative US has been available in our institution since 2006. Since 2008, BCS has been performed only under US-guided localization in our institution. Between 2006 and 2008, patients were assigned in a 1:1 ratio to either palpation-guided or US-guided tumorectomy. No intraoperative radiologic confirmation was obtained for the surgical specimens from any of the patients. The study was approved by the Research and Ethical Committee of Otto-von-Guericke University, Magdeburg, Germany.
Surgical Treatment
The cases were separated into palpation-and US-guided excision groups. In the palpation-guided group, the completeness of tumor removal was evaluated by palpation. An additional intraoperative resection of tissue may have been undertaken following any palpation of the excision cavity that yielded a suspect finding. Such intraoperative re-excisions were performed based on the surgeon's clinical judgment.
In the US group, intraoperative US-scanning was performed using a portable 14MHz probe (MicroMaxx, SonoSite, Bothell, WA). A US was performed immediately prior to the operation, and the resulting images were captured and stored for correlation with the preoperative sonography and the pathology findings. After localization of the tumor in the transverse and craniocaudal directions, the tumor size and excision margins were marked on the skin. The surgeon repeatedly performed US, placing the ultrasound probe in different positions to obtain clear surgical margins. Only experienced surgeons with at least 15 US-guided excisions took part in the study.
After specimen removal, an ex vivo US was performed by the surgeon to determine the accuracy of the complete tumor resection. The resection margins were measured in all orientations. The distance between the hypoechoic tumor edge and the resection margin was measured by the surgeon in millimeters. In the case of suspect close surgical margins, in which the distance was < 5 mm, re-excision of the shave margin from the excision cavity was performed intraoperatively. The re-excision specimen was also evaluated by US. In 12 of 56 cases, re-excisions were performed in > 1 direction. However, there was never > 1 re-excision in the same direction. After excision, the excised tissue was oriented by sutures as follows: "long-lateral", "short-caudal", and "white-nipple."
In the case of positive or close surgical margins for the primary surgical specimens, re-excision was undertaken in a second operation. The total excision volume was calculated by the pathologist and included the volume of the primary surgical excision specimen and the intraoperatively re-excised margins in any case of intraoperative re-excision.
Statistical Analysis
The statistical calculations were performed using SPSS version Table 1 presents the patient and tumor characteristics. The study population comprised 335 patients with breast cancer who were divided into 2 groups. Group 1 consisted of 137 (40.9%) patients treated with palpation-guided BCS with a median age of 63 years (25-94 years). Group 2 comprised 198 patients (59.1%) with a median age of 58 years (29-85 years) who underwent a US-guided tumor excision. The average tumor size determined by the pathologist was identical (16 mm) in both groups ( Table 1 ). The median excision volume was 103 mm 3 in group 1 and 116 mm 3 in group 2;
Results
Patients and Tumor Characteristics
this difference was not significant (P ¼ .359). Both groups were comparable for many preoperative parameters such as menopausal status, tumor histology, presence of intraductal component (ductal carcinoma in situ or lobular carcinoma in situ), tumor grade, hormone receptor status, and HER2 receptor status (Table 1) .
Tumor Margins
We investigated the influence of different tumor and patient characteristics on surgical margins. status of both groups and shows that most tumors (83.6%) were excised with adequate surgical margins. US-guided BCS was associated with significantly more (87.9%) clear excision margins than palpation-guided BCS, for which 72.3% of the margins were negative (P ¼ .001). The negativity of surgical margins was significantly influenced by age, menopausal status, presence or absence of an intraductal component surrounding the invasive breast cancer, histologic grade, and type of tumor (Table 2 ). Elderly postmenopausal women had a higher risk of positive surgical margins. Identification of an intraductal component in the histology was associated with increased risk of close or positive margins (61 of 241, 25.3%) in comparison with tumors without an intraductal component (12 of 94, 12.8%) (P ¼ .012). Lobular histological type and tumors with differentiation grade 2 were also associated with a higher rate of positive excision margins, at 55.6% and 27.4%, respectively (Table 2) . Hormone receptor status, HER2 status, and breast side had no significant influence on the surgical margins.
Tumor Margins and Localization Method Used
As mentioned in the "Tumor margins" section, the use of different methods for intraoperative tumor localization was significantly associated with the status of the surgical margins. With palpation-guided surgical excision, 38 of 137 (27.7%) excised tumors were associated with positive margins, whereas in the US group, only 24 of 198 (12.1%) had positive margins ( Table 2 ). The re-excision rate of surgical margins at the time of surgery was 39 of 137 (28.5%) in group 1 and 22 of 198 (11.1%) in group 2 (P < .0001). The shave margins were excised from the excision cavity in the direction indicated by palpation or US, respectively. The histological examination of shave margins demonstrated that in 18 of 22 cases in group 2 (81.1%), the intraoperatively undertaken US-guided re-excision correctly identified the problematic margin. In group 2, palpation-guided re-excision excised only 7 of 39 (17.9%) shave margins in the correct direction. Moreover, the re-excision rate via a second operation differed significantly between groups (Table 3 , P ¼ .004). Thirty-three of 137 (24.1%) patients in the palpation-guided group and only 23 of 198 (11.6%) patients in the US-guided group underwent a second operation. The closest component to the resection margin was an invasive tumor in 15 cases, a noninvasive component in 34 cases, and both in 7 cases.
Sensitivity and Specificity of Palpation-and US-Guided Tumor Excisions
Next we assayed the sensitivity and specificity of both methods for resections of positive margins on primary tumor specimens (Table 4) . US-guided excision was associated with a relatively high sensitivity (52.7%) and specificity (97.5%), whereas the sensitivity and specificity of palpation-guided surgical treatment were 15.5% and 65.9%, respectively. Palpation-guided excision was associated intraoperatively with very high levels of false-negative surgical margins. Moreover, the sensitivity and specificity of the 2 methods were higher for tumors consisting of an invasive component without an intraductal component. The difference was dramatic in USguided resections in which the true positive margins were recognized in 100% of cases if the tumors consisted only of invasive breast cancer (Table 4) .
These data clearly demonstrate that US-guided breast surgery is a safe method for identifying the true positive margins, especially for treatment of breast cancers without an intraductal component.
Discussion
BCS in combination with adjuvant radiation is now a standard treatment of early breast cancer and is as effective and safe as mastectomy.
1,2,27 However, the biggest challenge for the surgeon remains obtaining clear surgical margins, because tumor-positive excision margins have been shown to significantly increase the local recurrence of cancer. 11 In the case of tumor-positive margins, a re-excision or mastectomy would have to be performed, 28, 29 and either procedure is associated with increased costs and is uncomfortable for the patient. Therefore, efforts should be made to obtain clear surgical margins intraoperatively, thus reducing the rate of re-excision and the risk of local recurrence. One promising method for obtaining clear surgical margins during BCS is the intraoperative use of US. However, this method is not well characterized. US was initially predominantly used for imaging-guided breast biopsy and diagnostic procedures, 16, 17 and it can even detect breast cancers that are not visible via mammography. 30 In the late 1980s, Schwartz and coworkers used US as an 18 Since then, the feasibility of the method and even its superiority to the classical wire-guided lumpectomy for nonpalpable tumors has been demonstrated. 23, 24, [31] [32] [33] In other series, the combination of intraoperative US with wire-guided breast cancer excision was associated with improved surgical outcomes. 26 Little is known about the use of US-guided resection of palpable breast tumors. The fact that all palpable breast cancers could be detected by US 34 makes it an excellent tool for intraoperative localization of these tumors. Palpable tumors are usually excised based on the tactile perceptions of the surgeon. A few initial studies have demonstrated that US-guided excision of palpable tumors may improve the surgical outcome and patients' satisfaction. 12, [20] [21] [22] Although the use of US-guided localization has not always been associated with better results, 20 most studies have demonstrated its superiority to palpation-guided tumorectomy regarding surgical margins and re-excision rates. 19, 21, 22 In agreement with this finding, we found that US-guided tumor excision was associated with a reduced rate of second operations. The excision volume was not significantly larger than the median excision volume in the palpation-guided group and was comparable with that of other reports. 21, 35 In most cases, the positive margins were caused by an intraductal component. 36 The association of an intraductal component with an increased rate of positive surgical margins is well documented. 37 However, the tumor-associated intraductal component has not been significantly associated with an increased rate of positive margins in US-guided tumor excisions. 3, 12, 21, 35 This discrepancy could be due to the small number of patients investigated in previous studies or by the high number of intraductal components observed in our cohort.
In the group with US-guided excisions, significantly fewer invasive tumors were responsible for positive margins than in the palpation-guided group. Consistent with our results, Fisher and coworkers recently found that US-guided tumor excision was associated with a lower rate of residual disease. 20 Moreover, in the current study, the re-excision rate of surgical margins at the time of surgery was 28.5% for palpation-guided resections and only 11.1% for US-guided excisions. In 97.5% of cases, the surgeon was able to identify correctly the problematic margin by US. Regarding the specificity and sensitivity of the 2 methods, US-guided excision was associated with a relatively high sensitivity (52.7%) and specificity (97.5%) compared with those of the palpation-guided surgical treatment (15.5% and 65.9%, respectively). In a prospective study of a relatively small group of breast cancer patients, Olsha and coworkers obtained similar results. 22 The authors found a good overall correlation between US and pathological margins. 22 The low accuracy of tumor localization by palpation could be explained by the fact that dense breast tissue or benign changes such as fibrosis could limit the tactile perception of the surgeon. This is supported by the fact that most intraoperative re-excisions in the palpationguided group revealed residual mastopathic tissue on pathological analysis (data not shown). The density of the mastopathic tissue could give the surgeon the false sense of residual tumor and could lead to resections of the shave margins. On the other hand, the sensitivity and specificity of US-guided tumor excision was significantly decreased by the presence of an intraductal component in the pathological findings.
The superiority of US-guided BCS regarding re-excision operations has been well documented but predominantly in small collectives and for nonpalpable tumors. 19, [21] [22] [23] [24] 35 US-guided excision in our study cohort was associated with a lower re-excision rate. Thus, the use of intraoperative US could enable the surgeon to make immediate real-time evaluations of the resection margins with consequent re-excision of the shave margins, resulting in a reduced rate of second operations. US is a simple and relatively rapid, nontraumatic procedure that is easy to learn, requiring only 10 to 15 procedures to learn. 38, 39 The limitations of our study are as follows: (i) The study was retrospectively evaluated with all limitations of retrospective studies (selection bias, depending on the accuracy of the available records, uncontrolled nature, and so on);
(ii) The groups included different numbers of patients; and (iii) The cosmetic results and patients' satisfaction were not evaluated. The advantages of the present study are that it included the largest study population in the literature, the similarities of tumor and patient characteristics among the 2 groups, and the exclusion of nonpalpable and multifocal tumors.
Conclusion
US-guided tumor excision is associated with obtaining accurate surgical margins, a reduced number of re-operations, and high specificity in evaluating surgical margins. US-guided tumor localization makes the surgeon independent of other physicians and should become the standard procedure for BCS.
Clinical Practice Points
Breast-conserving surgery (BCS) is a standard treatment for early breast cancer. Obtaining clear surgical margins is the most important goal of BCS. Various localization methods have been used to obtain Ultrasonography-Guided Breast Surgery adequate surgical margins: palpation-guided, wire-guided, and radio-guided excision.
Here we described the use of ultrasonography to obtain clear surgical margins in BCS. We found that ultrasonography-guided tumor excision is superior to palpation-guided tumor surgery in regard to obtaining accurate surgical margins, a reduced number of re-operations, and high specificity in evaluating surgical margins. The fact that ultrasonography is a simple and relatively rapid, nontraumatic procedure that is easy to learn. It will make the surgeon independent of the radiologist or pathologist and will enable the surgeon to make immediate real-time evaluation of the resection margins.
